Sector: MedicalMAPP (NASDAQ: MAPP)
Headlines
- Stock-PR.com Announces Daily Stock Watch
Nov 12, 2009 09:55 AM | CAAS, CRAY, MAPP
- MAP Pharmaceuticals Secures $60 Million Committed Equity Financing Facility
Nov 12, 2009 07:02 AM | MAPP
- MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference
Nov 11, 2009 07:01 AM | MAPP
- MAP Pharmaceuticals Reports Third Quarter of 2009 Financial Results
Nov 05, 2009 07:02 AM | AZN, MAPP
- MAP Pharmaceuticals Completes Interim Safety Review of LEVADEX(TM) Open-Label Safety Extension in More Than 400 Patients
Oct 29, 2009 07:02 AM | MAPP
- MultiVu Video Feed: POSITIVE PHASE 3 TRIAL DATA FOR INVESTIGATIONAL NEW MIGRAINE TREATMENT PRESENTED IN LATE-BREAKING SESSION AT 14th ANNUAL INTERNATIONAL HEADACHE SOCIETY CONGRESS
Sep 10, 2009 12:00 PM | MAPP
- MAP Pharmaceuticals' Analysis of Positive Phase 3 LEVADEX(TM) Data To Be Presented in Late-Breaking Session at 14th Congress of the International Headache Society
Sep 10, 2009 07:00 AM | MAPP
- MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
Sep 02, 2009 07:01 AM | MAPP, MS
- FDA, Clinical Trial Updates: MAPP, CYTK, and HEB Post Big Gains
May 27, 2009 08:31 AM | ALTH, AMGN, BMY, CYTK, ICAD, MAPP
- MARKET SNAPSHOT: U.S. Stocks End With Solid Weekly Gains
Oct 05, 2007 04:37 PM | AA, BA, BCS, CMC, DIS, LWSN
- MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock
Aug 06, 2009 09:00 AM | MAPP
- MAP Pharmaceuticals, Inc. Announces Public Offering of Common Stock
Aug 05, 2009 04:48 PM | MAPP
- MAP Pharmaceuticals Reports Second Quarter of 2009 Financial Results
Aug 03, 2009 07:51 AM | AZN, MAPP
- MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration
Jul 09, 2009 08:31 AM | MAPP
- MAP Pharmaceuticals Phase 3 Trial of LEVADEX(TM) Migraine Product Candidate Meets All Four Primary Endpoints
May 26, 2009 07:30 AM | MAPP
- MAP Pharmaceuticals Announces Presentations at the American Thoracic Society International Conference
May 14, 2009 04:31 PM | MAPP
- MAP Pharmaceuticals to Present at the Deutsche Bank Securities 34th Annual Health Care Conference
May 13, 2009 04:05 PM | MAPP
- MAP Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
May 07, 2009 04:31 PM | MAPP
- MAP Pharmaceuticals Reports First Quarter of 2009 Financial Results
May 07, 2009 04:05 PM | MAPP
- MAP Pharmaceuticals to Present at the Cowen and Company 29th Annual Health Care Conference
Mar 11, 2009 04:05 PM | MAPP
- Form 4 MAP Pharmaceuticals, For: Nov 18 Filed by: HENWOOD GERALDINE (10K)
Nov 19, 2009 05:15 PM
- Form 4 GIANAKAKOS ANASTASIOS For: Nov 02 (10K)
Nov 04, 2009 02:58 PM
- Form 4 CHAI CHRISTOPHER Y For: Nov 02 (10K)
Nov 04, 2009 02:55 PM
- Form 4 GIANAKAKOS ANASTASIOS For: Oct 01 (10K)
Oct 05, 2009 07:00 PM
- Form 4 CHAI CHRISTOPHER Y For: Oct 01 (10K)
Oct 05, 2009 06:56 PM
- Form 4 GIANAKAKOS ANASTASIOS For: Sep 08 (10K)
Sep 10, 2009 01:40 PM
- Form 4 MAP Pharmaceuticals, For: Jul 14 Filed by: FirstMark Capital, L.L.C. (10K)
Jul 16, 2009 02:28 PM
- Form 4 GIANAKAKOS ANASTASIOS For: Jul 10 (10K)
Jul 14, 2009 07:01 PM
- Form 4 MAP Pharmaceuticals, For: Jul 02 Filed by: FirstMark Capital, L.L.C. (10K)
Jul 06, 2009 04:44 PM
- Form 4 MAP Pharmaceuticals, For: Jul 01 Filed by: FirstMark Capital, L.L.C. (10K)
Jul 02, 2009 06:18 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
MAPP
|
Compare to S&P
|
| YTD |
25.36 %
|
3.75 %
|
| 4 Weeks |
-3.21 %
|
-4.25 %
|
| 12 Weeks |
-4.58 %
|
-10.04 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 433.33 %
|
|
EPS Growth in Last Year: 180.00 %
|
|
Sales Growth in Last Quarter: 308.02 %
|
|
Sales Growth in Last Quarter: -0.01 %
|
|
